Search

Issue
Title
Authors
Vol 30, No 14 (2023)
The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Semiglazov V.F., Krivorotko P.V., Bekkeldiyeva N.B., Komyakhov A.V., Emelyanov A.S., Gorina A.O.
PDF
(Rus)
Vol 28, No 7 (2021)
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K.S., Vorontsova K.A., Kuko T.M., Prosvirnov A.A., Ganshina I.P., Lubennikova E.V., Kolyadina I.V., Zhukova L.G.
PDF
(Rus)
Vol 29, No 11/12 (2022)
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V.F., Krivorotko P.V., Komyakhov A.V., Semiglazova T.Y., Gigolaeva L.P., Tabagua T.T., Kazantseva M.D., Tergoeva A.P., Ulrikh D.G., Chervyak M.V., Klimenko V.V., Amirov N.S., Zhiltsova E.K., Semiglazov V.V.
PDF
(Rus)
Vol 26, No 12 (2019)
A clinical case of using ribociclib with an aromatase inhibitor in metastatic hormone-receptor-positive HER2-negative breast cancer with a rare location of metastasis
Fateeva A.V., Zyuzyukina A.V., Zukov R.A.
PDF
(Rus)
No 7 (2018)
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D.D., Iskhakova A.I., Kunafina R.I.
PDF
(Rus)
1 - 5 of 5 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies